These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16440929)

  • 21. Linezolid, quinupristin/dalfopristin, and daptomycin in dermatology.
    Wesson KM; Lerner DS; Silverberg NB; Weinberg JM
    Dis Mon; 2004 Jul; 50(7):395-406. PubMed ID: 15280870
    [No Abstract]   [Full Text] [Related]  

  • 22. Quinupristin-dalfopristin (RP 59500): an injectable streptogramin combination.
    Griswold MW; Lomaestro BM; Briceland LL
    Am J Health Syst Pharm; 1996 Sep; 53(17):2045-53. PubMed ID: 8870891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristin.
    Linden PK; Moellering RC; Wood CA; Rehm SJ; Flaherty J; Bompart F; Talbot GH;
    Clin Infect Dis; 2001 Dec; 33(11):1816-23. PubMed ID: 11668430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arthralgias and myalgias related to quinupristin-dalfopristin administration.
    Olsen KM; Rebuck JA; Rupp ME
    Clin Infect Dis; 2001 Feb; 32(4):e83-6. PubMed ID: 11181142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of streptogramin growth promoters in poultry and isolation of streptogramin-resistant Enterococcus faecium from humans.
    Kieke AL; Borchardt MA; Kieke BA; Spencer SK; Vandermause MF; Smith KE; Jawahir SL; Belongia EA;
    J Infect Dis; 2006 Nov; 194(9):1200-8. PubMed ID: 17041845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro combinations of five intravenous antibiotics with dalfopristin-quinupristin against Staphylococcus aureus in a 3-dimensional model.
    Duez JM; Adochitei A; Péchinot A; Siebor E; Sixt N; Neuwirth C
    J Chemother; 2008 Dec; 20(6):684-9. PubMed ID: 19129064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Superinfection with Enterococcus faecalis during quinupristin/dalfopristin therapy.
    Chow JW; Davidson A; Sanford E; Zervos MJ
    Clin Infect Dis; 1997 Jan; 24(1):91-2. PubMed ID: 8994760
    [No Abstract]   [Full Text] [Related]  

  • 28. [Other antimicrobials (linezolid, quinupristin/dalfopristin)].
    Yamaguchi K; Ohno A
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():756-61. PubMed ID: 12722312
    [No Abstract]   [Full Text] [Related]  

  • 29. Interaction between quinupristin/dalfopristin and cyclosporine.
    Stamatakis MK; Richards JG
    Ann Pharmacother; 1997 May; 31(5):576-8. PubMed ID: 9161651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of quinupristin/dalfopristin against gram-positive bacteria: clinical applications and therapeutic potential.
    Rubinstein E; Bompart F
    J Antimicrob Chemother; 1997 May; 39 Suppl A():139-43. PubMed ID: 9511078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of vancomycin-resistant enterococcus with quinupristin/dalfopristin and high-dose ampicillin.
    Bethea JA; Walko CM; Targos PA
    Ann Pharmacother; 2004 Jun; 38(6):989-91. PubMed ID: 15100393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In-vitro activity and killing effect of quinupristin/dalfopristin (RP59500) on nosocomial Staphylococcus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates.
    Sambatakou H; Giamarellos-Bourboulis EJ; Grecka P; Chryssouli Z; Giamarellou H
    J Antimicrob Chemother; 1998 Mar; 41(3):349-55. PubMed ID: 9578161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraventricular quinupristin/dalfopristin for the treatment of vancomycin-resistant Enterococcus faecium shunt infection.
    Tush GM; Huneycutt S; Phillips A; Ward JD
    Clin Infect Dis; 1998 Jun; 26(6):1460-1. PubMed ID: 9636880
    [No Abstract]   [Full Text] [Related]  

  • 34. Quinupristin/dalfopristin in vancomycin-resistant Staphylococcus aureus endophthalmitis.
    Stroh EM
    Arch Ophthalmol; 2012 Oct; 130(10):1323-4. PubMed ID: 23044949
    [No Abstract]   [Full Text] [Related]  

  • 35. Prospective, randomized study comparing quinupristin-dalfopristin with linezolid in the treatment of vancomycin-resistant Enterococcus faecium infections.
    Raad I; Hachem R; Hanna H; Afif C; Escalante C; Kantarjian H; Rolston K
    J Antimicrob Chemother; 2004 Apr; 53(4):646-9. PubMed ID: 14998986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycopeptide-resistant Enterococcus faecium infections in paediatric liver transplant recipients: safety and clinical efficacy of quinupristin/dalfopristin.
    Verma A; Dhawan A; Philpott-Howard J; Rela M; Heaton N; Vergani GM; Wade J
    J Antimicrob Chemother; 2001 Jan; 47(1):105-8. PubMed ID: 11152440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linezolid and quinupristin/dalfopristin: novel antibiotics for gram-positive infections of the skin.
    Schweiger ES; Scheinfeld NS; Tischler HR; Weinberg JM
    J Drugs Dermatol; 2003 Aug; 2(4):378-83. PubMed ID: 12884459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of quinupristin/dalfopristin versus vancomycin, alone or in combination with rifampicin, against methicillin-resistant Staphylococcus aureus in a rabbit arthritis model.
    Hamel A; Caillon J; Jacqueline C; Batard E; Potel G
    Int J Antimicrob Agents; 2008 Feb; 31(2):158-60. PubMed ID: 18006281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quinupristin/dalfopristin and linezolid: spectrum of activity and potential roles in therapy--a status report.
    Batts DH; Lavin BS; Eliopoulos GM
    Curr Clin Top Infect Dis; 2001; 21():227-51. PubMed ID: 11572153
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection Group.
    Nichols RL; Graham DR; Barriere SL; Rodgers A; Wilson SE; Zervos M; Dunn DL; Kreter B
    J Antimicrob Chemother; 1999 Aug; 44(2):263-73. PubMed ID: 10473234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.